Immunotoxins: Cancer Treatment and Research, cartea 37
Editat de Arthur E. Frankelen Limba Engleză Paperback – 27 sep 2011
Din seria Cancer Treatment and Research
- 5%
Preț: 689.30 lei - 5%
Preț: 2034.23 lei - 5%
Preț: 1065.68 lei - 5%
Preț: 1055.49 lei - 5%
Preț: 1370.28 lei - 5%
Preț: 1060.22 lei - 5%
Preț: 698.28 lei - 5%
Preț: 757.15 lei - 5%
Preț: 997.66 lei - 5%
Preț: 992.60 lei - 5%
Preț: 1001.34 lei - 5%
Preț: 881.90 lei - 5%
Preț: 722.90 lei - 5%
Preț: 1000.49 lei - 5%
Preț: 1008.19 lei - 5%
Preț: 693.36 lei - 5%
Preț: 698.28 lei - 5%
Preț: 356.31 lei - 5%
Preț: 1359.06 lei - 5%
Preț: 1368.74 lei - 5%
Preț: 1063.72 lei - 5%
Preț: 694.80 lei - 5%
Preț: 1060.41 lei - 5%
Preț: 1051.96 lei - 5%
Preț: 1053.89 lei - 5%
Preț: 1351.86 lei - 5%
Preț: 692.32 lei - 5%
Preț: 679.49 lei - 5%
Preț: 702.84 lei - 5%
Preț: 1359.76 lei - 5%
Preț: 1049.83 lei - 5%
Preț: 1056.88 lei - 5%
Preț: 1063.39 lei
Preț: 2036.86 lei
Preț vechi: 2144.06 lei
-5%
Puncte Express: 3055
Preț estimativ în valută:
360.54€ • 420.62$ • 312.19£
360.54€ • 420.62$ • 312.19£
Carte tipărită la comandă
Livrare economică 26 februarie-12 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461284192
ISBN-10: 1461284198
Pagini: 588
Ilustrații: XX, 566 p.
Dimensiuni: 160 x 240 x 31 mm
Greutate: 0.81 kg
Ediția:Softcover reprint of the original 1st ed. 1988
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
ISBN-10: 1461284198
Pagini: 588
Ilustrații: XX, 566 p.
Dimensiuni: 160 x 240 x 31 mm
Greutate: 0.81 kg
Ediția:Softcover reprint of the original 1st ed. 1988
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1. Introduction.- I. Toxin Structure.- 2. Toxin structure.- 3. Structure—activity relationships in diphtheria toxin and Pseudomonas aeruginosa exotoxin A.- II. How Toxins Work.- 4. How protein toxins enter and kill cells.- 5. Mechanism of action of ricin and related toxins on the inactivation of eukaryotic ribosomes.- III. Toxin Selection and Modification.- 6. Toxin selection and modification — Overview.- 7. Toxin selection and modification: Utilization of the A chain of ricin.- 8. Genetic engineering of immunotoxins.- 9. Diphtheria-related peptide hormone gene fusions: A molecular genetic approach to chimeric toxin development.- 10. Immunotoxins containing ricin.- 11. Pseudomonas exotoxin — Immunotoxins.- 12. Immunotoxins containing single chain ribosome-inactivating proteins.- IV. Covalent Linking Agents.- 13. Antibody-toxin conjugation.- 14. Effect of chemical linkage upon the stability and cytotoxic activity of A chain immunotoxins.- V. Antibody Selection.- 15. Immunotoxins: Selection of cell-surface antigens and their corresponding monoclonal antibodies.- VI. Nonantibody Ligands.- 16. Hormone, lectin and toxin-toxin conjugates.- 17. Growth factors and other ligands.- VII. Purification and Chemical Characterization.- 18. Purification and biochemical characterization of immunotoxins.- VIII. Enhancers.- 19. Immunotoxin enhancers.- 20. Enhancement of immunotoxin action: Manipulation of the cellular routing of proteins.- IX. Cytotoxicity.- 21. Methods for quantifying immunotoxin efficacy.- 22. Kinetic analysis of cytotoxicity.- 23. Isolation and analysis of somatic cell mutants resistant to toxin conjugates.- X. Animal Studies.- 24. Immunotoxin therapy: Assessment by animal models.- 25. Prevention of carbohydrate-mediated clearance of ricin-containing immunotoxinsby the liver.- 26. Human immune response to immunotoxins.- XI. Clinical Studies.- 27. Treatment of leukemia patients with T101 ricin A chain immunotoxins.- 28. Clinical studies: Solid tumors.- 29. Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation.- 30. Conclusion.